Dyax Quick Ratio (DYAX) starting from the third quarter 2015 to third quarter 2014, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Dyax Corp  (DYAX)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare

Dyax's Quick Ratio

DYAX's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the third quarter 2015, Quick Ratio fell to 10.8 above Dyax Corp average.

Within Medical Laboratories industry 3 other companies have achieved higher Quick Ratio than Dyax in third quarter 2015. While Quick Ratio total ranking in the third quarter 2015 has deteriorated compared to the prior quarter from 194 to 296.

Explain Quick Ratio?
How much Cash & cash equivalents DYAX´s has?
What are DYAX´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

DYAX Quick Ratio (Sep 30 2015)
Q3		 (Jun 30 2015)
Q2		 (Mar 31 2015)
Q1		 (Dec 31 2014)
Q4		 (Sep 30 2014)
Q3
Y / Y Current Liabilities Change 63.54 % 40.34 % 36.33 % 25.11 % -0.55 %
Y / Y Cash & cash equivalent Change 64.14 % 109.99 % -2.82 % 65.78 % 298.53 %
Quick Ratio MRQ 10.8 17.87 9 8.43 10.76
DYAX's Total Ranking # 296 # 194 # 350 # 378 # 303
Seq. Current Liabilities Change 29.37 % 9.18 % -7.75 % 25.51 % 11.02 %
Seq. Cash & cash equivalent Change -21.76 % 116.71 % -1.5 % -1.72 % 0.09 %



Quick Ratio third quarter 2015 Company Ranking
Within: No.
Medical Laboratories Industry # 4
Healthcare Sector # 131
Overall Market # 296


Quick Ratio Statistics
High Average Low
17.87 7.27 1.76
(Jun 30 2015)   (Sep 30 2012)




Financial Statements
Dyax's Current Liabilities $ 29 Millions Visit DYAX's Balance sheet
Dyax's Cash & cash equivalent $ 308 Millions Visit DYAX's Balance sheet
Source of DYAX's Sales Visit DYAX's Sales by Geography


Cumulative Dyax's Quick Ratio

DYAX's Quick Ratio for the trailling 12 Months

DYAX Quick Ratio

 (Sep 30 2015)
12 Months		 (Jun 30 2015)
12 Months		 (Mar 31 2015)
12 Months		 (Dec 31 2014)
12 Months		 (Sep 30 2014)
12 Months
Y / Y Current Liabilities TTM Growth 41.54 % 24.43 % 15.69 % 2.17 % -10.63 %
Y / Y Cash & cash equivalent TTM Growth 58.59 % 77.84 % 89.02 % 228.43 % 364.18 %
Quick Ratio TTM 11.53 11.62 9.86 10.69 10.29
Total Ranking TTM # 2985 # 2981 # 3198 # 3028 # 3182
Seq. Current Liabilities TTM Growth 13.58 % 8.42 % 7.7 % 6.71 % -0.15 %
Seq. Cash & cash equivalent TTM Growth 12.7 % 27.82 % -0.71 % 10.87 % 26.39 %

Quick ratio ranking by company, industry and sector >> Back to DYAX Financial Strength Comparisons >> Go to Compare DYAX Quick Ratio to its Competitors

On the trailing twelve months basis Due to growth in Current Liabilities in the Q3 2015 to $28.54 millions, cumulative Quick Ratio decreased to 11.53 above the DYAX average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Laboratories industry 16 other companies have achieved higher Quick Ratio than Dyax. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2015 from 2981 to 2985.

Explain Quick Ratio?
How much Cash & cash equivalents DYAX´s has?
What are DYAX´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Laboratories Industry # 17
Healthcare Sector # 403
Within the Market # 2985


trailing twelve months Quick Ratio Statistics
High Average Low
11.62 6.62 1.24
(Jun 30 2015)   (Mar 31 2012)




Companies with similar Quick Ratio in the quarter ending Sep 30 2015, within Medical Laboratories Industry Quick RatioSep 30 2015 MRQ Cash & cash equivalentSep 30 2015 MRQ Current Liabilities
Lightwave Logic Inc   17.95 $ 2.712  Millions$ 0.151  Millions
Invitae Corporation  17.41 $ 147.252  Millions$ 8.457  Millions
Exact Sciences Corporation  14.61 $ 343.509  Millions$ 23.514  Millions
Dyax Corp  10.80 $ 308.385  Millions$ 28.542  Millions
Natera Inc   7.12 $ 222.767  Millions$ 31.287  Millions
Check Cap Ltd  6.87 $ 14.249  Millions$ 2.073  Millions
Viridian Therapeutics Inc   5.74 $ 12.139  Millions$ 2.114  Millions
Incyte Corporation  4.08 $ 635.562  Millions$ 155.823  Millions
Biocept Inc   3.70 $ 12.542  Millions$ 3.391  Millions
Caredx Inc   3.25 $ 33.954  Millions$ 10.454  Millions
Vyant Bio Inc   3.11 $ 20.243  Millions$ 6.505  Millions
Veracyte Inc   3.00 $ 46.234  Millions$ 15.432  Millions
Capforce Inc   3.00 $ 11.187  Millions$ 3.735  Millions
Icagen, Inc.  2.85 $ 5.500  Millions$ 1.928  Millions
Genomic Health Inc  2.37 $ 98.013  Millions$ 41.323  Millions

Date modified: 2026-08-29T13:43:07+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.